[FATE] QoQ Quarter Result on 30-Sep-2018 [#Q3]

Stock
[FATE] Fate Therapeutics, Inc.
Announcement Date
01-Nov-2018
Financial Year
2018
Quarter
30-Sep-2018 [#Q3]
Profit Trend
QoQ- 14.61%
YoY- -57.08%
Quarter Report
FATE's Result
FATE's Financial Summary
View:
Show?
Quarter Result
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
Revenue 2,817 2,632 1,661 1,026 1,027 1,026 1,027 96.31%
PBT -23,478 -19,760 -16,027 -16,782 -19,654 -14,135 -12,497 52.43%
Tax 1,015 1,091 817 339 376 331 -131 -
NP -23,478 -19,760 -16,027 -16,782 -19,654 -14,135 -12,497 52.43%
Tax Rate - - - - - - - -
Total Cost 26,295 22,392 17,688 17,808 20,681 15,161 13,524 55.96%
Ratio Analysis
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
NP Margin -833.44 -750.76 -964.90 -1,635.67 -1,913.73 -1,377.68 -1,216.85 -22.35%
Per Share
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
EPS -0.36 -0.30 -0.25 -0.31 -0.37 -0.27 -0.29 15.55%
EPS Diluted -0.36 -0.30 -0.25 -0.31 -0.37 -0.27 -0.29 15.55%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.